Surmodics | SRDX - Frais De Vente Et D'Administration



Frais De Vente Et D'Administration Changement Date
Abbott USD 3.27B 138M 2026-03
Align Technology USD 465.34M 23.67M 2026-03
Anika Therapeutics USD 10.01M 14K 2025-12
Arrowhead Research USD 41.74M 4.28M 2026-03
Artivion USD 55.75M 4.54M 2025-12
Baxter International USD 728M 33M 2026-03
Boston Scientific USD 1.78B 53M 2026-03
EDAP TMS EUR 8.81M 1.57M 2025-09
Edwards Lifesciences USD 522.2M 80.7M 2026-03
Haemonetics USD 109.15M 7.54M 2025-12
Heron Therapeutics USD 23.74M 605K 2025-12
J&J USD 6.03B 719M 2026-03
Merit Medical Systems USD 110.47M 4.36M 2026-03
Mesa Laboratories USD 27.31M 380K 2024-09
Nektar Therapeutics USD 10.17M 10.17M 2025-12
Option Care Health USD 174.56M 2.42M 2026-03
Stryker USD 2.15B 17M 2026-03
Trinity Biotech USD 6.19M 2.18M 2025-09